PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Symptom | |infection |
| Sentences | 596 |
| PubMedID- 23861838 | Univariate linear regression analysis identified the following variables as predictors of efavirenz plasma level at week 4; cyp2b6*6 genotype (9.8%, p<0.0001), country (4.8%, p<0.0001), co infection with hepatitis b at recruitment (0.6%, p = 0.061), cyp3a5*1 genotype (1.5%, p = 0.019), abcb1 c.3435c>t (0.8%, p = 0.082), abcb1 c.4036a>g (2.4%, p = 0.003), slco1b1*1b (0.8%, p = 0.084). |
| PubMedID- 25899746 | Chronic infection with hepatitis b virus (hbv) plays an important role in the etiology of hepatocellular carcinoma (hcc). |
| PubMedID- 26083843 | Moreover, this syndrome may be a first sign of infection with epstein-barr virus, hepatitis b virus, hiv or other viral infections. |
| PubMedID- 25728498 | Background & aims: early age at infection with hepatitis b virus (hbv) increases the risk of chronic infection. |
| PubMedID- 24212770 | The primary risk factors for hcc include infection with hepatitis b and hepatitis c viruses, and long-term exposure to aflatoxin 3. |
| PubMedID- 23714072 | infection with the hepatitis b and c viruses (hbv and hcv) causes significant morbidity andmortality. |
| PubMedID- 21760650 | infection with hepatitis b is a major public health problem, particularly in asian populations. |
| PubMedID- 22898798 | Liver disease associated to persistent infection with the hepatitis b virus (hbv) continues to be a major health problem of global impact. |
| PubMedID- 23098744 | infection with hepatitis b virus (hbv) continues to be a major global cause of acute and chronic liver disease with high mortality. |
| PubMedID- 23669295 | Association between cytotoxic t-lymphocyte associated protein 4 gene +49 a/g polymorphism and chronic infection with hepatitis b virus: a meta-analysis. |
| PubMedID- 23825999 | Hepatitis delta virus (hdv) is a defective single- stranded rna virus that needs co-infection with hepatitis b virus (hbv) to replicate. |
| PubMedID- 22701774 | It appears that the transmission of, and infection with, hepatitis b virus poses the greatest risk for both patients and the dental team, based on the incidence and risk of transmission. |
| PubMedID- 22143175 | According to the 2009 national health and nutrition survey, the rate of infection with the hepatitis b antigen among koreans aged 30 and above is 4.5% in men and 3.4% in women. |
| PubMedID- 23467038 | It has been well known that chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv), excessive alcohol consumption, and nonalcoholic fatty liver disease serve as major risk factors for hcc development 2. |
| PubMedID- 20480646 | Human parvovirus b19/parv4 infection is probably associated with chronic hepatitis b/c. |
| PubMedID- 23087759 | Exclusion criteria included simultaneous infection with hepatitis b or human immunodeficiency virus (hiv), active liver disease, existence of liver disease with a cause other than hepatitis c, hepatocellular carcinoma (hcc), liver transplantation history, uncontrolled diabetes mellitus, malignant neoplastic disease, severe cardiac or pulmonary disease, autoimmune disorders, retinopathy, morbid obesity (weight over 125 kg), severe depression, uncontrolled psychotic disorders and existing drug addiction. |
| PubMedID- 24313162 | The major risk factors for developing hcc are viral infection (i.e., with the hepatitis b or c viruses), chronic alcoholism, and exposure to toxic substances called aflatoxins. |
| PubMedID- 21714878 | Other exclusion criteria were co-infection with hepatitis b, immunodeficiency virus, decompensated liver disease of any cause, coronary heart disease, diabetes mellitus requiring insulin therapy, autoimmune disorders, active alcohol or drug addiction and/or any other unstable chronic medical condition. |
| PubMedID- 26214477 | Reduced cortisol in the absence of bacterial infection in patients with hepatitis b virus cirrhosis. |
| PubMedID- 21346778 | Chronic infection with hepatitis b virus (hbv) is the most common cause of liver cancer worldwide, as well as a major risk factor for development of cirrhosis and end-stage liver disease.1 the hepatitis b vaccine is highly effective in preventing new infections, but ∼360 million people still suffer from chronic hepatitis b and there are ∼600 000 annual deaths from hbv-related causes.1 recent genome-wide association studies identified single nucleotide polymorphisms (snps) located within the human leukocyte antigen (hla) class ii genes hla-dpa1 and hla-dpb1 to be associated with chronic hepatitis b.2, 3 replication studies performed on two of these snps (rs3077 and rs9277535) confirmed and strengthened results from the genome-wide association studies.2 class ii hla genes encode proteins expressed on the surface of antigen-presenting cells such as macrophages, dendritic cells and b cells, and thereby have a critical role in presentation of antigens to cd4+ t-helper lymphocytes. |
| PubMedID- 23559765 | Aims: co-infection of hgv with hepatitis b virus (hbv) and hepatitis c virus (hcv) infection has been reported however; very limited data is available from india. |
| PubMedID- 23618464 | infection with hepatitis b virus (hbv) and hepatitis c virus (hcv) affects the liver and results in a broad spectrum of disease outcomes 1. |
| PubMedID- 24019767 | To find out the cause of thrombocytopenia and leukocytopenia, we performed serology tests for infection with hepatitis b virus, hepatitis c virus, epstein-barr virus and helicobacter pylori; however, there were no remarkable findings. |
| PubMedID- 22467683 | Chronic infections with the hepatitis b virus (hbv) and hepatitis c virus (hcv) are the major risks of hepatocellular carcinoma (hcc), and great efforts have been made towards the understanding of the different mechanisms that link the viral infection of hepatic lesions to hcc development. |
| PubMedID- 22208719 | infection with hepatitis b virus (hbv), which can cause acute and chronic liver diseases, remains one of the most serious viral infections in humans. |
| PubMedID- 24240052 | Odds ratios (or) for hcc were obtained through multiple logistic regression models, controlling for potentially confounding factors, including chronic infection with hepatitis b/c viruses. |
| PubMedID- 23297244 | infection with the hepatitis b virus (hbv) may lead to an acute or chronic infection. |
| PubMedID- 23300165 | Background: the long-term evolution and outcomes of infection with a hepatitis b virus (hbv) surface antigen (hbsag) gene mutant (hereafter, "hbsag-mutant hbv") among immunized children remain unclear. |
| PubMedID- 25355887 | Chronic infection with hepatitis b virus (hbv) is a risk factor for developing liver diseases such as hepatocellular carcinoma (hcc). |
| PubMedID- 25798607 | Co-infection with hepatitis b virus is common among hiv-infected individuals . |
| PubMedID- 24084133 | Chronic infection with hepatitis b virus has a profound effect on health-related quality of life. |
| PubMedID- 26347404 | Lack of association between polymorphisms of the tlr4 gene and infection with the hepatitis b and c viruses. |
| PubMedID- 24791430 | In the case of co-infection with hiv, hepatitis b and c, some of these persistent parasitosis may induce more significant morbidity. |
| PubMedID- 24602336 | Further complicating the picture is the co-infection with hepatitis b virus (hbv) and human immunodeficiency virus (hiv-1), which ultimately alters the natural course of the disease. |
| PubMedID- 25842192 | Reactivation of resolved infection with the hepatitis b virus immune escape mutant g145r during dasatinib treatment for chronic myeloid leukemia. |
| PubMedID- 25984154 | infection with hepatitis b virus (hbv) is a well-known and an important cause of liver disease in patients on hemodialysis (hd). |
| PubMedID- 21151658 | High-risk factors for hcc include exposure to genotoxins, such as the mycotoxin aflatoxin b1 (afb1), and infection with hepatitis b and c viruses 3. |
| PubMedID- 25646622 | Chronic infection with hepatitis b virus (hbv) affects over 300 million individuals worldwide . |
| PubMedID- 21687523 | Chronic infection with the hepatitis b virus (hbv) occurs in approximately 6% of the world's population and carriers of the virus are at risk for complicating hepatocellular carcinoma. |
| PubMedID- 23202511 | Epidemiological studies indicate that chronic infection with hepatitis b virus (hbv) is the leading cause for the development of hepatocellular carcinoma (hcc) 1. |
| PubMedID- 22291932 | Patients eligible to enroll in actg 5192 had a cd4+ t cell count of >300 cells/ul, had a plasma hiv-1 rna level >5000 copies/ml, were antiretroviral therapy-naïve or had not received antiretroviral therapy for at least twelve weeks, had no evidence of infection with hepatitis b or c virus and had serum transaminase levels no greater than grade 1 by actg toxicity tables at entry. |
| PubMedID- 24885392 | Background: early age at infection with hepatitis b virus (hbv) increases the risk of chronic hbv infection. |
| PubMedID- 24497877 | infection with hepatitis b virus (hbv) is a major global health problem affecting over 350 million people in the world (1). |
| PubMedID- 25713800 | Chronic infection with hepatitis b virus (hbv) is the leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. |
| PubMedID- 25099228 | Chronic infection with hepatitis b virus (hbv) is a risk factor for developing hepatocellular carcinoma (hcc). |
| PubMedID- 25962123 | infection with hepatitis b virus (hbv) results in disparate degrees of tissue injury: the virus can either replicate without pathological consequences or trigger immune-mediated necroinflammatory liver damage. |
| PubMedID- 24004495 | The following covariates assessed at the date of stored samples were considered for the adjusted analyses: calendar year, duration of time between the date of sample and the analysis time, age, total cholesterol, hdl, cd4+ cell count and viral load, cumulative exposure to nonnucleoside reverse transcriptase inhibitors (nnrtis), nucleoside reverse transcriptase inhibitor (nrtis) and protease inhibitor (pis) prior to sample, and co-infection with hepatitis b or c. . |
| PubMedID- 23722085 | We conducted a study to investigate hiv and hepatitis delta virus (hdv) coinfection among patients with chronic hepatitis b virus (hbv) infection and the triple infection's (hiv/hbv/hdv) clinical implications in india, an intermediate hbv endemic region, with an estimated hiv-positive population of 2.5 million. |
| PubMedID- 21375724 | This is attributed to the interval between initial hbv infection and the detection of hepatitis b surface antigen (hbsag), resulting in a long window phase during which the virus is transmissible . |
| PubMedID- 25535101 | infection with hepatitis b virus (hbv) may lead to subclinical, acute or chronic hepatitis. |